First Horizon Advisors, Inc. Castle Biosciences Inc Transaction History

First Horizon Advisors, Inc.

$3.53 Billion
Q1 2025

A detailed history of First Horizon Advisors, Inc. transactions in Castle Biosciences Inc stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 1,810 shares of CSTL stock, worth $28,905. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,810

Previous 2,010 9.95%

Holding current value

$28,905

Previous $53,000 32.08%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	SELL	$18.76 - $32.72 $3,752 - $6,544	-200 Reduced 9.95%	1,810 $36,000
Q4 2024 Feb 03, 2025	SELL	$26.52 - $34.67 $1,591 - $2,080	-60 Reduced 2.9%	2,010 $53,000
Q3 2024 Nov 08, 2024	SELL	$17.4 - $31.47 $100,624 - $181,991	-5,783 Reduced 73.64%	2,070 $59,000
Q4 2023 Feb 06, 2024	SELL	$12.19 - $22.43 $3,047 - $5,607	-250 Reduced 3.09%	7,853 $169,000
Q3 2023 Oct 27, 2023	BUY	$13.28 - $20.3 $8,924 - $13,641	672 Added 9.04%	8,103 $136,000
Q2 2023 Aug 03, 2023	BUY	$11.66 - $26.0 $5,153 - $11,492	442 Added 6.32%	7,431 $101,000
Q1 2023 May 15, 2023	BUY	$19.47 - $28.49 $350 - $512	18 Added 0.26%	6,989 $158,000
Q4 2022 Feb 10, 2023	SELL	$18.08 - $30.0 $4,646 - $7,710	-257 Reduced 3.56%	6,971 $164,000
Q3 2022 Nov 09, 2022	BUY	$22.51 - $34.32 $150,411 - $229,326	6,682 Added 1223.81%	7,228 $188,000
Q2 2022 Aug 02, 2022	SELL	$16.0 - $45.99 $832 - $2,391	-52 Reduced 8.7%	546 $11,000
Q1 2022 May 10, 2022	BUY	$33.17 - $46.98 $4,577 - $6,483	138 Added 30.0%	598 $27,000
Q4 2021 Feb 09, 2022	SELL	$39.06 - $67.58 $3,945 - $6,825	-101 Reduced 18.0%	460 $19,000
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $26,336 - $33,988	-438 Reduced 43.84%	561 $37,000
Q3 2021 Nov 09, 2021	BUY	$60.13 - $77.6 $37,100 - $47,879	617 Added 161.52%	999 $66,000
Q2 2021 Aug 09, 2021	BUY	$50.07 - $76.78 $5,557 - $8,522	111 Added 40.96%	382 $28,000
Q1 2021 May 11, 2021	SELL	$58.92 - $97.33 $3,594 - $5,937	-61 Reduced 18.37%	271 $18,000
Q4 2020 Feb 11, 2021	BUY	$43.6 - $73.05 $6,496 - $10,884	149 Added 81.42%	332 $22,000
Q3 2020 Nov 12, 2020	BUY	$38.47 - $52.03 $7,040 - $9,521	183 New	183 $9,000

Others Institutions Holding CSTL

# of Institutions

192

Shares Held

26.7M

Call Options Held

9.5K

Put Options Held

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $420M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Account

First Horizon Advisors, Inc. Castle Biosciences Inc Transaction History